The Hereditary Cancer Group at the IGTP provides another tool for the better management of patients diagnosed with NF1
In a study, published in Human Mutation led by Meritxell Carrió and Eduard Serra of the IGTP in collaboration with scientists from the ICO Hereditary Cancer Program, scientists studied 8 PNF tumours to find information to help doctors predict how tumours will develop. They looked at the tissue characteristics of the tumors and then compared this to the genetic make-up of the cells within the tumour.
![](/media/upload/gif/20180702-nf1_153053893658.jpg)